-
A new “cognitive biotype” of depression, and why it may not respond to medication
Stanford researchers describe a subtype affecting over a quarter of people with depression that resists common antidepressants. We look at what it means and where TMS fits.
From the Optimind Blog
Plain-language takes on the latest TMS research, what it means for patients on Vancouver Island, and how treatment really works.
-
Health Canada, the FDA, and what “approved” actually means for TMS
TMS approvals can be confusing. Here’s a plain guide to what’s cleared for what, from depression to OCD, and why it matters for your treatment options.
-
“Will it hurt?” and 9 other questions people ask before their first TMS session
The honest answers to what patients most want to know, from what a session feels like to whether you can drive home afterward.
-
TMS and memory: what the research on cognition is actually showing
Small studies suggest TMS combined with cognitive training may support memory in older adults. We separate the promising signal from the hype.
-
Why effective depression treatment is still hard to access in Canada
TMS is proven and safe, so why isn’t it everywhere yet? A look at access, funding, and what’s changing, including here on Vancouver Island.
-
How to choose a TMS provider: questions worth asking
Not all TMS clinics are the same. Experience, technology, and assessment all matter. Here’s what to look for before you commit.
-
What Stanford’s SAINT trial means for TMS patients on Vancouver Island
A landmark Stanford trial saw nearly 80% of participants with severe, treatment-resistant depression reach remission using an accelerated form of TMS. Here’s what the research actually shows, and what it means if you’re considering treatment here on the Island.